Literature DB >> 9705368

Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes.

J Bikandi1, R S Millán, M D Moragues, G Cebas, M Clarke, D C Coleman, D J Sullivan, G Quindós, J Pontón.   

Abstract

There is a clear need for the development of a rapid and reliable test for the identification of Candida dubliniensis and for the discrimination of this species from Candida albicans. In the present study we have investigated the potential use of C. dubliniensis-specific antigens as a basis for its identification. We produced an anti-C. dubliniensis serum which, after adsorption with C. albicans blastospores, was found to differentially label C. dubliniensis isolates in an indirect immunofluorescence test. In this test, the antiserum reacted with blastospores and germ tubes of C. dubliniensis and with blastospores of Candida krusei and Rhodotorula rubra but did not react with blastospores of several other Candida species including C. albicans. The antiserum also reacted with C. albicans germ tubes. The anti-C. dubliniensis adsorbed serum reacted with specific components of 25, 28, 37, 40, 52, and 62 kDa in the C. dubliniensis extract and with a variety of antigens from other yeast species. The antigens from non-C. dubliniensis yeasts showing reactivity with the anti-C. dubliniensis adsorbed serum are mostly expressed within the cell walls of these yeast species, and this reactivity does not interfere with the use of the anti-C. dubliniensis adsorbed serum in an indirect immunofluorescence test for the rapid identification of C. dubliniensis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705368      PMCID: PMC105138     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

Review 1.  Antifungal susceptibility testing: technical advances and potential clinical applications.

Authors:  M A Pfaller; J H Rex; M G Rinaldi
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

2.  Clinical isolates of Candida guilliermondii include Candida fermentati.

Authors:  R M San Millán; L C Wu; I F Salkin; P F Lehmann
Journal:  Int J Syst Bacteriol       Date:  1997-04

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  [Oral mycoses in the AIDS era].

Authors:  W Delgado; J M Aguirre
Journal:  Rev Iberoam Micol       Date:  1997-03       Impact factor: 1.044

5.  Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users.

Authors:  P Boerlin; F Boerlin-Petzold; C Durussel; M Addo; J L Pagani; J P Chave; J Bille
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

6.  Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients.

Authors:  D Sullivan; D Bennett; M Henman; P Harwood; S Flint; F Mulcahy; D Shanley; D Coleman
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

7.  Variability in expression of antigens responsible for serotype specificity in Candida albicans.

Authors:  B Barturen; J Bikandi; R San Millán; M D Moragues; P Regulez; G Quindós; J Pontón
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

8.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

9.  Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus.

Authors:  M J McCullough; B C Ross; B D Dwyer; P C Reade
Journal:  Microbiology       Date:  1994-05       Impact factor: 2.777

10.  Antigenic studies of Candida. I. Observation of two antigenic groups in Candida albicans.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1961-10       Impact factor: 3.490

View more
  23 in total

1.  One-year prevalence of Candida dublinienis in a Dutch university hospital.

Authors:  J F Meis; F M Lunel; P E Verweij; A Voss
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes.

Authors:  Y C Chen; J D Eisner; M M Kattar; S L Rassoulian-Barrett; K LaFe; S L Yarfitz; A P Limaye; B T Cookson
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies.

Authors:  Agnes Marot-Leblond; Bertrand Beucher; Sandrine David; Sandrine Nail-Billaud; Raymond Robert
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

4.  Oral Candida isolates colonizing or infecting human immunodeficiency virus-infected and healthy persons in Mexico.

Authors:  Luis Octavio Sánchez-Vargas; Natalia Guadalupe Ortiz-López; María Villar; María Dolores Moragues; José Manuel Aguirre; Miguel Cashat-Cruz; Jose Luis Lopez-Ribot; Luis Alberto Gaitán-Cepeda; Guillermo Quindós
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  New monoclonal antibody specific for Candida albicans germ tube.

Authors:  A Marot-Leblond; L Grimaud; S Nail; S Bouterige; V Apaire-Marchais; D J Sullivan; R Robert
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel.

Authors:  I Polacheck; J Strahilevitz; D Sullivan; S Donnelly; I F Salkin; D C Coleman
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Serological differentiation of experimentally induced Candida dubliniensis and Candida albicans infections.

Authors:  M D Moragues; M J Omaetxebarria; N Elguezabal; J Bikandi; G Quindós; D C Coleman; J Pontón
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

8.  Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans.

Authors:  Christian O Mosca; María D Moragues; José Llovo; Asmaa Al Mosaid; David C Coleman; José Pontón
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

9.  Differentiation of Candida albicans and Candida dubliniensis by using recombinant human antibody single-chain variable fragments specific for hyphae.

Authors:  Joseph M Bliss; Mark A Sullivan; Jane Malone; Constantine G Haidaris
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

10.  In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.

Authors:  M A Pfaller; S A Messer; S Gee; S Joly; C Pujol; D J Sullivan; D C Coleman; D R Soll
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.